Autoimmune disease. a problem of defective apoptosis

Arthritis & Rheumatism

Volumn 37, Issue 10, 1994, Pages 1415-1420

  Mountz, John D ^a,b   Wu, Jianguo ^a,b   Cheng, Jianhua ^a,b   Zhou, Tong ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b Veterans Administration   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; METHOTREXATE; PROTEIN P53; STEROID;

APOPTOSIS; AUTOIMMUNITY; CELL DEATH; CELL PROLIFERATION; ETIOLOGY; GENE INDUCTION; HUMAN; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TUMOR SUPPRESSOR GENE;

ANTIGENS, CD95; ANTIGENS, SURFACE; APOPTOSIS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CELL DIVISION; GENES, MYC; GENES, P53; HUMAN; MUTATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028036918     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.1780371002     Document Type: Article

References (62)

1. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis.
2. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen.
3. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice.
4. Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene.
5. The defect of Fas mRNA expression in MRL‐lpr mice is associated with insertion of the retrotransposon, ETn.
6. Mutation at murine motheaten locus are within the hematopoietic cell protein‐tyrosine phosphatase (Hcph) gene.
7. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene.
8. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.
9. Monoclonal antibody‐mediated tumor regression by induction of apoptosis.
10. Monoclonal‐antibody‐mediated apoptosis in adult T‐cell leukaemia.
11. Identification of a soluble form of the fas molecule that protects cells from fas‐mediated apoptosis.
12. Apoptosis and programmed cell death and maturity.
13. Toward an understanding of the molecular mechanisms of physiological cell death.
14. Apoptotic signals delivered through the T‐cell receptor of a T‐cell hybrid require the immediate‐early gene Nur77.
15. Requirement for the orphan steroid receptor Nur77 in apoptosis of T‐cell hybridomas.
16. Autoimmune gld mutation uncouples suicide and cytokine/proliferation pathways in activated, mature T cells.
17. Fas transduces activation signals in normal human T lymphocytes.
18. Transcriptional activation of the inducible nuclear receptor gene Nur77 by nerve growth factor and membrane depolarization in PC12 cells.
19. Dephosphorylation of a 65 kD protein delivers a signal for Fas‐mediated apoptosis (abstract)
20. Apoptotic cell death induced by c‐myc is inhibited by bcl‐2.
21. Cooperative interaction between c‐myc and bcl‐2 proto‐oncogenes.
22. Role for c‐myc in activation‐induced apoptotic cell death in T cell hybridomas.
23. Thymocyte apoptosis induced by p53‐dependent and independent pathways.
24. p53 is required for radiation‐induced apoptosis in mouse thymocytes.
25. p53 mutations increase resistance to ionizing radiation.
26. Apoptosis.
27. Susceptibility to apoptosis is differentially regulated by c‐myc and mutated Ha‐ras oncogenes and is associated with endonuclease availability.
28. Variations in thymocyte susceptibility to clonal deletion during ontogeny: implications for neonatal tolerance.
29. The apoptosis endonuclease and its regulation.
30. A calciumdependent nuclease from apoptotic rat thymocytes is homologous with cyclophilin.
31. Activation interferes with the APO‐1 pathway in mature human T cells.
32. APO‐1‐induced apoptosis of leukemia cells from patients with adult T‐cell leukemia.
33. Apoptosis in toremifene‐induced growth inhibition of human breast cancer cells in vivo and in vitro.
34. Evidence supporting a role for programmed cell death in focal cerebralischemia in rats.
35. Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus.
36. Temporal covariation of soluble interleukin‐2 receptor levels, daily stress, and disease activity in rheumatoid arthritis.
37. The soluble interleukin‐2 receptor in rheumatic disease.
38. Assessment of in vivo frequency of mutated T cells in patients with systemic lupus erythematosus.
39. Possible clearance of effete polymorphonuclear leucocytes from synovial fluid by cytophagocytic mononuclear cells: implications for pathogenesis and chronicity in inflammatory arthritis.
40. Importance of apoptosis in the histopathology of drug related lesions in the large intestine.
41. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
42. Bcl‐2 expression in adult and embryonic non‐haematopoietic tissues.
43. In vitro identification of a subpopulation of fibroblasts that produces high levels of collagen in scleroderma patients.
44. Heterogeneity in hormone responses and patterns of collagen synthesis in cloned dermal fibroblasts.
45. Role of mesenchymal cell death in lung remodeling after injury.
46. Regulation of fibroplasia in cutaneous wound repair.
47. Lethal effect of the anti‐Fas antibody in mice.
48. + Cos cells and anti‐Fas antibody for in vivo localization of Fas/Fas ligand binding and apoptosis sites in autoimmune lpr and gld mice (abstract)
49. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferation.
50. Murine “viable motheaten” mutation reveals a gene critical to the development of both B and T lymphocytes.
51. Origin of CD4‐CD8‐B220+ T cells in MRL‐lpr/lpr mice: clues from a T cell receptor beta transgenic mouse.
52. Abnormal thymocyte development and production of autoreactive T cells in TCR transgenic autoimmune mice.
53. Defective maintenance of T cell tolerance to a superantigen in MRL‐lpr/lpr.
54. lpr T cells are necessary for autoantibody production in lpr mice.
55. Conventional B cells, not B‐1 cells, are responsible for producing autoantibodies in lpr mice.
56. A role for endogenous retroviral sequences in the regulation of lymphocyte activation.
57. Association of murine lupus and thymic full‐length endogenous retroviral expression maps to a bone marrow stem cell.
58. Retroviruses, apoptosis and autogenes.
59. Virus‐like particles in synovial fluids from patients with rheumatoid arthritis.
60. Correction of autoimmune disease in CD2‐fas transgenic mice.
61. The structure of the human CD2 gene and its expression in transgenic mice.
62. Human CD2 3′‐flanking sequences confer high‐level, T cell‐specific, positionindependent gene expression in transgenic mice.